PEMFEXY (pemetrexed) Eagle pharms Patent: 7,772,209 Expiration: May 24, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Paten…
Drug Patent Expirations for the Week of May 22, 2022 Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. There are seven patents protecting this drug. Drug patent litigation…
The post New patent expiration for Alexza Pharms drug ADASUVE appea…
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Annual Drug Patent Expirations for PROTONIX+IV Protonix Iv is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers. There are three…
The post New patent expiration for Wyeth Pharms drug PROTONIX IV appeared fir…
New patent expiration for Wyeth Pharms drug PROTONIX IV Read Post »
Annual Drug Patent Expirations for PROTONIX+IV Protonix Iv is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers. There are three…
The post New patent expiration for Wyeth Pharms drug PROTONIX IV appeared fir…
New patent expiration for Wyeth Pharms drug PROTONIX IV Read Post »
TARGINIQ (naloxone hydrochloride; oxycodone hydrochloride) Purdue pharma lp Patent: 9,511,066 Expiration: May 10, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent …
Drug Patent Expirations for the Week of May 8, 2022 Read Post »
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are thirteen patents protecting this drug. XHANCE drug…
The post New patent expiration for Optinose Us drug XHANCE appeared first o…
New patent expiration for Optinose Us drug XHANCE Read Post »
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this drug. Drug patent…
The post New patent expiration for Purdue Pharma drug TARGINIQ appeared…
New patent expiration for Purdue Pharma drug TARGINIQ Read Post »
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent expiration for Gw Res drug EPIDIOLEX appeared first on Drug…
Annual Drug Patent Expirations for NEXTERONE Nexterone is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Baxter Hlthcare drug NEXTERONE appear…
New patent expiration for Baxter Hlthcare drug NEXTERONE Read Post »
EPIDIOLEX (cannabidiol) Gw res ltd Patent: 10,195,159 Expiration: May 7, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Patent …
Drug Patent Expirations for the Week of May 1, 2022 Read Post »